Expression of apoptosis-related proteins in endometriomas and benign and malignant ovarian tumours

Virchows Archiv

Volumn 443, Issue 1, 2003, Pages 38-43

  Fauvet, Raffaèle ^b   Poncelet, Christophe ^b   Hugol, Danièle ^b   Lavaur, Anne ^b   Feldmann, Gérard ^b   Daraï, Emile ^a  

^a HÔPITAL TENON   (France)

^b NONE

Author keywords

Apoptosis; Endometriomas; Ovarian cancer; Ovarian tumours

Indexed keywords

CELL PROTEIN; FAS ANTIGEN; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN P21; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; BENIGN TUMOR; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOMETRIUM TUMOR; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; ANTIGENS, CD95; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CELL COUNT; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENDOMETRIOSIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0042666933     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-003-0813-3     Document Type: Article

References (45)

1. Athanassiadou P, Petrakakou E, Sakelariou V, Zerva C, Liossi A, Michalas S, Athanassiades P (1998) Expression of p53, bcl-2 and heat shock protein (hsp72) in malignant and benign ovarian tumours. Eur J Cancer Prev 7:225-231
2. Attardi LD, Lowe SW, Brugarolas J, Jacks T (1996) Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis. EMBO J 15:3693-3701
3. Bayramoglu H, Duzcan E (2001) Atypical epithelial changes and mutant p53 gene expression in ovarian endometriosis. Pathol Oncol Res 7:33-38
4. Ben-Hur H, Gurevich P, Huszar M, et al (1999) Apoptosis and apoptosis-related proteins in the epithelium of human ovarian tumors: immunohistochemical and morphometric studies. Eur J Gynaecol Oncol 20:249-253
5. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, Hannon GJ (1995) Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377:552-557
6. Chan WY, Cheung KK, Schorge JO, et al (2000) Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers. Am J Pathol 156:409-417
7. Chang CC, Hsieh YY, Tsai FJ, Tsai CH, Tsai HD, Lin CC (2002) The proline form of p53 codon 72 polymorphism is associated with endometriosis. Fertil Steril 77:43-45
8. Darai E, Bringuier AF, Walker-Combrouze F, Feldmann G, Madelenat P, Scoazec JY (1998) Soluble adhesion molecules in serum and cysts fluids from patients with cystic tumours of the ovary. Hum Reprod 13:2831-2835
9. Darai E, Leblanc M, Walker-Combrouze F, Bringuier AF, Madelenat P, Scoazec JY (1998) Expression of cadherins and CD44 isoforms in ovarian endometrial cysts. Hum Reprod 13:1346-1352
10. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P (1995) Mice lacking p21CIP1/WAFI undergo normal development, but are defective in G1 checkpoint control. Cell 82:675-684
11. Gottlieb TM, Oren M (1998) p53 and apoptosis. Semin Cancer Biol 8:359-368
12. Goumenou A, Panayiotides I, Matalliotakis I, Vlachonikolis I, Tzardi M, and Koumantakis E (2001) Bcl-2 and Bax expression in human endometriotic and adenomyotic tissues. Eur J Obstet Gynecol Reprod Biol 99:256-260
13. Harada M, Suganuma N, Furuhashi M, Nagasaka T, Nakashima N, Kikkawa F, Tomoda Y, Furui K (1996) Detection of apoptosis in human endometriotic tissues. Mol Hum Reprod 2:307-315
14. Heaps JM, Nieberg RK, Berek JS (1990) Malignant neoplasms arising in endometriosis. Obstet Gynecol 75:1023-1028
15. Hsieh YY, Tsai FJ, Chang CC, Chen WC, Tsai CH, Tsai HD, Lin CC (2001) p21 gene codon 31 arginine/serine polymorphism: non-association with endometriosis. J Clin Lab Anal 15:184-187
16. Hsu SY, Hsueh AJ (2000) Tissue-specific Bcl-2 protein partners in apoptosis: an ovarian paradigm. Physiol Rev 80:593-614
17. International Federation of Gynecology and Obstetrics (1971) Classification and staging of malignant tumours in the female pelvis. Acta Obstet Gynecol Scand 50:1-7
18. Jenkins S, Olive DL, Haney AF (1986) Endometriosis: pathogenetic implications of the anatomic distribution. Obstet Gynecol 67:335-338
19. Jones RK, Searle RF, Bulmer JN (1998) Apoptosis and bcl-2 expression in normal human endometrium, endometriosis and adenomyosis. Hum Reprod 13:3496-3502
20. Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-257
21. Knudson CM, Tung KS, Tourtellotte WG, Brown GA, Korsmeyer SJ (1995) Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270:96-99
22. Kokawa K, Shikone T, Otani T, et al (2001) Apoptosis and the expression of bax and bcl-2 in hyperplasia and adenocarcinoma of the uterine endometrium. Hum Reprod 16:2211-2218
23. Lebovic DI, Mueller MD, Taylor RN (2001) Immunobiology of endometriosis. Fertil Steril 75:1-10
24. Marone M, Scambia G, Mozzetti S, et al (1998) Bcl-2, bax, bcl-xl, and bcl-xs expression in normal and neoplastic ovarian tissues. Clin Cancer Res 4:517-524
25. McCurrach ME, Connor TM, Knudson CM, Korsmeyer SJ, Lowe SW (1997) Bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc Natl Acad Sci U S A 94:2345-2349
26. McLaren J, Prentice A, Charnok-Jones DS, Sharkey AM, Smith SK (1997) Immunolocalization of the apoptosis regulating proteins bcl-2 and bax in human endometrium and isolated peritoneal fluid macrophages in endometriosis. Hum Reprod 12:146-152
27. Meresman GF, Vighi S, Buquet RA, Contreras-Ortiz O, Tesone M, Rumi LS (2000) Apoptosis and expression of Bcl-2 and Bax in eutopic endometrium from women with endometriosis. Fertil Steril 74:760-766
28. Nagata S (1994) Fas and Fas ligand: a death factor and its receptor. Adv Immunol 57:129-144
29. Nakayama K, Toki T, Zhai YL, Lu X, Horiuchi A, Nikaido T, Konishi I, Fujii S (2001) Demonstration of focal p53 expression without genetic alterations in endometriotic lesions. Int J Gynecol Pathol 20:227-231
30. Nezhat FR, Kalir T (2002) Comparative immunohistochemical studies of endometriosis lesions and endometriotic cysts. Fertil Steril 78:820-824
31. Nezhat F, Cohen C, Rahaman J, Gretz H, Cole P, Kalir T (2002) Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts. Cancer 94:2935-2940
32. Owen-Schaub LB, Zhang W, Cusack JC, et al (1995) Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol 15:3032-3040
33. Ridley JH (1968) The histogenesis of endometriosis. A review of facts and fancies. Obstet Gynecol 23:1-35
34. Ryan IP, Taylor RN (1997) Endometriosis and infertility: new concepts. Obstet Gynecol Surv 52:365-371
35. Sampson JA (1927) Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 14:422-469
36. Schneider J, Jimenez E, Rodriguez F, del Tanago JG (1998) c-myc, c-erb-B2, nm23 and p53 expression in human endometriosis. Oncol Rep 5:49-52
37. Stovall DW, Bowser LM, Archer DF, Guzick DS (1997) Endometriosis-associated pelvic pain: evidence for an association between the stage of disease and a history of chronic pelvic pain. Fertil Steril 68:13-18
38. Suganuma N, Harada M, Furuhashi M, Nawa A, Kikkawa F (1997) Apoptosis in human endometrial and endometriotic tissues. Horm Res 48:42-47
39. Vaux DI, Cory S, Adams JM (1988) Bcl-2 gene promotes haematopoetic cell survival and co-operates with c-myc to immortalize pre-B cells. Nature 335:440-442
40. Vercellini P, Trespidi L, De Giorgi O (1996) Endometriosis and pelvic pain: relation to disease stage and localization. Fertil Steril 65:299-304
41. Vogt J (1872) Untersuchungen uber die Entwicklungsgeschichte der Geburtshelferkroete (Alytes obstetricians). Jent & Gassman, Solothurn, Switzerland
42. Watanabe H, Kanzaki H, Narukawa S, Inoue T, Katsuragawa H, Kaneko Y, and Mori T (1997) Bcl-2 and Fas expression in eutopic and ectopic human endometrium during the menstrual cycle in relation to endometrial cell apoptosis. Am J Obstet Gynecol 176:360-368
43. Werness BA, Freedman AN, Piver MS, Romero-Gutierrez M, Petrow E (1999) Prognostic significance of p53 and p21(wafl/cip1) immunoreactivity in epithelial cancers of the ovary. Gynecol Oncol 75:413-418
44. Yin C, Knudson CM, Korsmeyer SJ, Van Dyke T (1997) Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385:637-640
45. Zusman I, Gurevich P, Gurevich E, Ben-Hur H (2001) The immune system, apoptosis and apoptosis-related proteins in human ovarian tumors (a review). Int J Oncol 18:965-972